TBA
BSX icon

Tower Bridge Advisors’s Boston Scientific BSX Stock Holding History

Tower Bridge Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$831K Buy
13,250
+2,150
+19% +$172K 0.08% 134
2025
Q4 		$1.06M Buy
11,100
+8,150
+276% +$799K 0.11% 108
2025
Q3 		$288K Buy
+2,950
New +$306K 0.03% 166

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Bridge Advisors's BSX Position: Q1 2026 in Review

Tower Bridge Advisors increased its Boston Scientific (BSX) stake by 19% in Q1 2026, buying an estimated $172K and bringing the position to 13,250 shares worth $831K. The position accounts for 0.08% of the portfolio, ranked #134.

Tower Bridge Advisors first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.06M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Tower Bridge Advisors held 13,250 shares of Boston Scientific worth $831K as of Q1 2026.
  • Tower Bridge Advisors bought 2,150 Boston Scientific shares in Q1 2026, an estimated $172K.
  • Boston Scientific made up 0.08% of Tower Bridge Advisors's portfolio in Q1 2026, its #134 holding.
  • Tower Bridge Advisors first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • Tower Bridge Advisors's Boston Scientific position peaked at $1.06M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.